Biogen Inc. buy Needham & Company LLC
Start price
28.06.24
/
50%
€212.90
Target price
28.06.25
€274.57
Performance (%)
-49.72%
End price
29.06.25
€107.05
Summary
This prediction ended on 29.06.25 with a price of €107.05. Massive losses of -49.72% were the result for the BUY prediction by Needham___Company_LL. Needham___Company_LL has a follow-up prediction for Biogen Inc. where he still thinks Biogen Inc. is a Buy. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | 8.456% | 8.456% | 76.007% |
| iShares Core DAX® | -1.427% | -1.427% | 2.278% |
| iShares Nasdaq 100 | -1.979% | 0.174% | 35.587% |
| iShares Nikkei 225® | -3.848% | 6.534% | 59.081% |
| iShares S&P 500 | -0.472% | 0.237% | 24.692% |
Comments by Needham___Company_LL for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $294.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten